Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti… - Blood, The Journal …, 2008 - ashpublications.org
In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-
phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti… - Blood, 2008 - europepmc.org
In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-
phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti… - BLOOD, 2008 - research.unipg.it
In this randomized multicenter study of 136 patients, 6 courses of CHOP
(cyclophosphamide/doxorubicin/vincristine/pred-nisone) followed by rituximab (CHOP-R) …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Parti… - Blood, 2008 - research.uniupo.it
In this randomized multicenter study of 136 patients, 6 courses of CHOP
(cyclophosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti… - 2008 - pubmed.ncbi.nlm.nih.gov
In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-
phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti… - BLOOD, 2008 - air.unimi.it
In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-
phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F DE MARCO, F Benedetti, U Vitolo, C Patti… - BLOOD, 2008 - iris.uniroma1.it
In this randomized multicenter study of 136 patients, 6 courses of CHOP
(cyclophosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti… - BLOOD, 2008 - boa.unimib.it
In this randomized multicenter study of 136 patients, 6 courses of CHOP (cyclo-
phosphamide/doxorubicin/vincristine/prednisone) followed by rituximab (CHOP-R) were …

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti… - Blood, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In this randomized multicenter study of 136
patients, 6 courses of CHOP (cyclo-phosphamide/doxorubicin/vincristine/prednisone) …

[引用][C] Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular …

M LADETTO, F DE MARCO, A GALLAMINI… - Blood, 2008 - pascal-francis.inist.fr
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus
conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis …